Publications
Download CSV
Download XLSX
Download TXT
Tables
2025 (13)
2024 (138)
2023 (212)
2022 (243)
2021 (271)
2020 (184)
2019 (163)
2018 (579)
2017 (788)
2016 (753)
2015 (640)
2014 (585)
2013 (461)
2012 (330)
2011 (191)
2010 (67)
2009 (38)
2008 (38)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (5741)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Niroula A
JSON
CSV
XLSX
TXT
Family name
Niroula
Given name
Abhishek
Initials
A
ORCID
ORCID
0000-0002-5904-0635
Affiliations
Protein Structure and Bioinformatics Group, Department of Experimental Medical Science, Lund University, Lund, Sweden.
25 publications
PubMed
DOI
Crossref
JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism.
Zon RL
,
Sekar A
,
Clapham K
, ...,
Natarajan P
,
Ebert BL
Blood
144
(20) 2149-2154 [2024-11-14; online 2024-08-05]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Sequence variants influencing the regulation of serum IgG subclass levels.
Olafsdottir TA
,
Thorleifsson G
, Lopez de Lapuente Portilla A, ...,
Nilsson B
,
Stefansson K
Nat Commun
15
(1) 8054 [2024-09-14; online 2024-09-14]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis.
Uddin MM
, Saadatagah S,
Niroula A
, ...,
Ballantyne CM
,
Natarajan P
Nat Commun
15
(1) 7858 [2024-09-09; online 2024-09-09]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Deciphering the genetics and mechanisms of predisposition to multiple myeloma.
Went M
, Duran-Lozano L,
Halldorsson GH
, ...,
Houlston R
,
Nilsson B
Nat Commun
15
(1) 6644 [2024-08-05; online 2024-08-05]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1.
Saadatagah S, Naderian M,
Uddin M
, ..., Kullo IJ,
Ballantyne CM
JAMA Cardiol
9
(6) 497-506 [2024-06-01; online 2024-04-10]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.
Lin AE
,
Bapat AC
,
Xiao L
, ...,
Ellinor PT
,
Ebert BL
Circulation
149
(18) 1419-1434 [2024-04-30; online 2024-02-15]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Association of Somatic TET2 Mutations With Giant Cell Arteritis.
Robinette ML,
Weeks LD
, Kramer RJ, ...,
Rao DA
,
Ebert BL
Arthritis & rheumatology (Hoboken, N.J.)
76
(3) 438-443 [2024-03-00; online 2024-02-02]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial.
Bhattacharya R
,
Uddin MM
,
Patel AP
, ..., Grinspoon SK,
Natarajan P
Blood Adv
8
(4) 959-967 [2024-02-27; online 2024-01-10]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation.
Chen CW,
Zhang L
, Dutta R, ...,
Sperling AS
, Goodell MA
Cell Stem Cell
30
(11) 1503-1519.e8 [2023-11-02; online 2023-10-19]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Functional and molecular profiling of hematopoietic stem cells during regeneration.
Rydström A,
Grahn THM
,
Niroula A
, ..., Larsson J,
Karlsson S
Exp. Hematol.
127
(-) 40-51 [2023-11-00; online 2023-09-04]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
Yu Z
, Fidler TP,
Ruan Y
, ..., Tall AR,
Natarajan P
J. Clin. Invest.
133
(18) - [2023-09-15; online 2023-09-15]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood.
Schuermans A
, Nakao T,
Ruan Y
, ...,
Natarajan P
,
Honigberg MC
J Am Heart Assoc
12
(13) e030220 [2023-07-04; online 2023-06-22]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Clonal Hematopoiesis and Risk of Incident Lung Cancer.
Tian R
, Wiley B,
Liu J
, ...,
Bolton KL
,
Cao Y
J Clin Oncol
41
(7) 1423-1433 [2023-03-01; online 2022-12-08]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential.
Nakao T
,
Bick AG
, Taub MA, ..., NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium ,
Natarajan P
Sci Adv
8
(14) eabl6579 [2022-04-08; online 2022-04-06]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke.
Bhattacharya R
,
Zekavat SM
, Haessler J, ...,
Natarajan P
,
Reiner AP
Stroke
53
(3) 788-797 [2022-03-00; online 2021-11-08]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Association of clonal hematopoiesis with chronic obstructive pulmonary disease.
Miller PG, Qiao D,
Rojas-Quintero J
, ...,
Ebert BL
, COPDGene Study Investigators, National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine Consortium
Blood
139
(3) 357-368 [2022-01-20; online 2021-12-03]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Functional dissection of inherited non-coding variation influencing multiple myeloma risk.
Ajore R,
Niroula A
,
Pertesi M
, ...,
Houlston R
,
Nilsson B
Nat Commun
13
(1) 151 [2022-01-10; online 2022-01-10]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis.
Kim PG
,
Niroula A
,
Shkolnik V
, ...,
Natarajan P
,
Ebert BL
J. Exp. Med.
218
(12) - [2021-12-06; online 2021-10-26]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Distinction of lymphoid and myeloid clonal hematopoiesis.
Niroula A
, Sekar A, Murakami MA, ...,
Natarajan P
,
Ebert BL
Nat. Med.
27
(11) 1921-1927 [2021-11-00; online 2021-10-18]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing.
Mattsson J, Ekdahl L, Junghus F, ..., Teige I,
Nilsson B
Nat Commun
12
(1) 1277 [2021-02-24; online 2021-02-24]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
S100A6 is a critical regulator of hematopoietic stem cells.
Grahn THM
,
Niroula A
,
Végvári Á
, ..., Zubarev RA,
Karlsson S
Leukemia
34
(12) 3323-3337 [2020-12-00; online 2020-06-19]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
How good are pathogenicity predictors in detecting benign variants?
Niroula A
,
Vihinen M
PLoS Comput Biol
15
(2) e1006481 [2019-02-00; online 2019-02-11]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression.
Ali M, Ajore R, Wihlborg AK, ..., Weinhold N, Nilsson B
Nat Commun
9
(1) 1649 [2018-04-25; online 2018-04-25]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.
Carraro M, Minervini G, Giollo M, ...,
Moult J
,
Tosatto SCE
Hum. Mutat.
38
(9) 1042-1050 [2017-09-00; online 2017-05-16]
Abhishek Niroula
DDLS Fellow
PubMed
DOI
Crossref
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges.
Daneshjou R
, Wang Y, Bromberg Y, ..., Brenner SE, Morgan AA
Hum. Mutat.
38
(9) 1182-1192 [2017-09-00; online 2017-07-07]
Abhishek Niroula
DDLS Fellow
SciLifeLab Data Centre
Publications
9.5.1